News

Gilead, Glympse Bio collaborate on use of biomarker technology in NASH Clinical Development

Glympse Bio’s synthetic biomarkers will be used to determine clinical trial participants’ stage of disease to determine responses to treatment in Gilead’s NASH clinical program.

Oct 30, 2019

By : Team ABLE

Call for Concept Proposal in the area of Developmental Disorders and Diseases of Infancy and Early Childhood

Fresh perspective and ingenious ideas are invited in order to landscape technologies for primary care and wellness centers.

Oct 30, 2019

By : Team ABLE

Hempcorp's secures 10,000-acre plantation site in Uttarakhand

The company will be managing operations in Uttarakhand and has plans for a variety-based product chain from hemp.

Oct 30, 2019

By : Team ABLE

Biocon ranked No. 6 in Science Careers' Top 20 Global Pharma & Biotech Employers List 2019

Ranked at No. 6 among global pharma and biotech companies in 2019, Biocon has moved up from No. 7 in 2018 and No. 9 in 2017.

Oct 29, 2019

By : Team ABLE

Keiretsu Global Forum appoints Gaurav Malhotra as head of newly-formed healthcare committee

A Wharton Business School alumnus, Malhotra is the managing partner of IKIZIA Advisors, a global healthcare network.

Oct 29, 2019

By : Team ABLE